Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of the Company for the Quarter-II and half year ended on September 30, 2026.

OrchidPharm~W -- A Dhanuka Group Company ---------------------------------- November 11, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai- 400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Sub: Prior Intimation of Board Meeting scheduled to be held on November 14, 2026 Dear Sir/Madam, With reference to captioned subject and in accordance with Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to intimate that the meeting of Board of Directors of Orchid Pharma Limited ("the Company") is scheduled to be held on Saturday, November 14, 2026, inter alia, to consider and approve Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of the Company for the Quarter-II and half year ended on September 30, 2026. Further, in continuation to our earlier intimation dated September 28, 2026 stating the 'Trading Window Closure Period', we would like to inform that the Trading Window for dealing in the securities of the Company has been closed from October 01, 2026 ('Trading Window Closure commencement date') and shall continue to remain closed till the date on which 48 hours ends ('Trading Window Closure end date') after declaration of Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of the Company for the Quarter-II and half year ended on September 30, 2026 or such extended date, as may be deemed necessary. You are requested to take the above intimation on record. Thanking You, For Orchid Pharma Limited Kapil Dayya Company Secretary & Compliance Officer M.No.F10698 +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151,159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India.